Head-hunter Katie Davis is consistently keeping up to date with the latest news within the biotech industry, whether that be funding news, acquisitions, spin outs and expansions, legal updates, layoffs and restructuring, collaborations or general product updates. In this blog, we explore the latest updates throughout Q4 2024. You can subscribe to Katies biotech funding updates over on LinkedIn to keep up to date with the ever-growing biotech market.
Part one covers funding rounds from Angle, Pre-Seed through Series E, part two focuses on IPO, corporate and Grant funding details.
Key stats:
- Total Funding: $27.27B
- October funding: $9.34B
- November funding: $6.42B
- December funding: $11.50B
October angel investment:
143,949 Biodimension Technology Private Limited, (India) is at the forefront of the field of tissue engineering, leveraging advanced techniques to develop human tissues and organs in the lab.
Pre-seed funding:
October:
535,859 Regenesome (Japan) is a biotechnology company that specializes in developing anti-aging technology to solve the problems of aging.
1,000,000 Potato AI (WA, USA) enables high-quality science by providing repeatable, well-defined protocols and software pipelines. We’re a team of scientists and engineers who are passionate about making science faster and more reliable.
Unknown Bullseye Biosciences(MA, USA) is a therapeutics discovery company revolutionizing drug development through robotics and evolution. Their platform operationalizes cutting-edge directed evolution technology by incorporating automation and NGS.
December:
2,100,000 Rowan (USA) is a molecular design and simulation tool used by scientists for modeling and analyzing molecular structures and behavior.
Unknown Sentinal4D (United Kingdom) uses AI for cancer drug discovery and personalized tumor diagnoses at the single-cell level.
Seed funding:
October:
681,439 AAX Biotech AB (Sweden) is a research-driven biotech company with proprietary technologies that solve unmet needs in the development of next-generation antibody therapeutics.
1,000,000 Mithradote Bio, Inc. (CA, USA) is a biotechnology company developing a novel medication to help prevent drug-facilitated sexual assault.
1,097,903 MONCYTE Health (Finland) is developing a patented technology to optimize the treatment and prevention of cardiovascular disease.
2,160,464 4Tissue (Belgium) is a research and clinical development firm that develops solutions to solve the limitations of cell-based therapies.
2,220,434 Llusern Scientific (Australia) specializes in rapid and affordable point-of-care molecular diagnostics developed to detect infections.
2,500,000 Avenue Biosciences (CA, USA) is a transatlantic biotech business that specializes on innovative protein engineering technologies.
2,776,260 aitiologic (Austria) is an Austrian precision medicine firm that creates AI-powered solutions for early disease identification and tailored therapy.
4,000,000 Ataraxis AI(NY, USA) is an AI precision medicine company transforming cancer diagnostics and patient outcomes through the power of AI.
4,600,000 Antiverse (United Kingdom) is dedicated to engineering the future of drug development to change the course of people’s lives.
5,000,000 MEDIC Life Sciences (CA, USA) is focusing on cancer drug targets in 3D tumor models using its proprietary CRISPR functional genomics platform.
5,300,000 clock.bio (United Kingdom) aims to extend and improve quality of life by reversing the harmful effects of time in our cells, harnessing the regenerative capabilities of human pluripotent stem cells
5,486,222 Generare (France) is a biotech startup that discovers next-generation medicines and high-value molecules hiding in soil bacteria.
9,000,000 Holobiome (MA, USA) is an owner and operator of a therapeutic company intended to treat diseases of the enteric and central nervous systems.
10,333,234 ikarovec (United Kingdom) is working on early stage assets intended for the treatment of diabetic macular edama.
15,000,000 Booster Therapeutics(Germany) is pioneering a new class of medicines that activate proteasomes (the cell’s natural quality control machinery) to treat a range of complex indications.
16,000,000 Shift Bioscience(United Kingdom) Shift Bioscience is harnessing AI-powered virtual cells to create a universal therapeutic approach. Cell reprogramming with Yamanaka factors can reverse aging in human cells and ameliorate disease in mammals but its tumor-inducing potential hampers clinical development.
17,200,000 Integrated Biosciences, Inc. (CA, USA) is a platform that is built around a proprietary synthetic biology toolkit, featuring advanced optogenetic tools that enable precise temporal and spatial control of complex pathways and difficult-to-drug targets.
17,200,000 Tolerance Bio (USA) is a biopharmaceutical company focused on manipulating immune tolerance via the thymus.
20,000,000 Passkey Therapeutics(MA, USA) is pioneering a new class of medicines, Synergistic Multifunctional Therapeutics or SMThs, designed to address complex diseases by targeting rare combinations of proteins that work together.
20,000,000 Archon Biosciences (DC, USA) is a biotechnology firm that promotes next-generation antibody treatments through AI and computational protein design.
31,000,000 Epitopea (United Kingdom) is a transatlantic cancer immunotherapeutics company.
Unknown Ruoyi Biotech (China) is a developer of macromolecular drug delivery technology.
Unknown Ottimo Pharma (United Kingdom) is a private biotech firm focused on improving cancer treatment outcomes and reducing the overall healthcare burden.
Unknown TikkunLev Therapeutics‘ (USA) mission is to improve the treatment of heart failure by tackling the basic biology of failing heart muscle.
November:
1,241,700 BioPhenoMA Inc. (Japan) develops an AI-powered platform for detecting ultra-trace proteins that helps accelerate new drug discovery phases.
1,669,792 Oncobit AG (Switzerland) enabling personalized cancer care by developing precise and highly sensitive diagnostic and monitoring tests.
2,000,000 Autoimmunity BioSolutions (TX, USA) is working on a next-generation immuno-corrective therapy that restores normal immune function in a genetically defined subgroup of autoimmune patients, where the autoimmune pathology is driven by an SNP.
2,250,000 Anivance AI 久浪智醫I Co., Ltd. (Taiwan) is a leader in intelligent healthcare innovation with state-of-the-art human organ model solutions.
2,093,038 Chromodynamics (The Netherlands) is a deep tech company creating a range of multispectral cameras.
2,265,005 PrecisionPhage Ltd (Finland) is a biotech business that specializes on bacteriophage technologies.
2,600,000 Amplified Sciences, Inc. (IN, USA) is a life science diagnostics company focusing on detecting and pre-empting the risks of debilitating diseases.
2,636,374 Embio Diagnostics Ltd (Cyprus) is a rapidly growing biotechnology company that designs and develops innovative, portable, biosensor-based and digital devices for rapid diagnostics.
2,750,000 Bectas Therapeutics (TX, USA) is a biotech company that develops monoclonal antibody therapies for cancer.
3,694,083 BIORCE (Spain) is an innovating medtech startup committed to transforming drug development through the use of artificial intelligence.
4,000,000 Mithrl (CA, USA) is a software development company that builds the custom workflows for NGS data on-demand.
5,500,000 Converge Bio (DE, USA) integrates Generative AI with biological data.
6,279,113 Biolevate (France) is an AI company that helps healthcare professionals accelerate scientific innovation and improve knowledge management.
10,000,000 CrossBridge Bio (TX, USA) operates as a biotechnology company, innovates ADC therapeutics through stable dual linker payload technology.
13,000,000 Aizen Therapeutics (CA, USA) is an AI-driven biotech company developing Mirror Peptides, a new class of biologic medicines.
30,000,000 Valora Therapeutics, Inc. (CA, USA) is a biotechnology company that provides engineering of chimeric antibodies .
Unknown NanoVation Therapeutics™ (Canada) provides technologies utilizing lipid nanoparticles for the safe and efficient delivery of nucleic acid tissues.
December:
1,243,746 New Wave Biotech (United Kingdom) creates bioprocess optimisation software to accelerate R&D and reduce production cost of alt protein and Synbio products.
1,529,910 Dia Beta Labs Ltd (United Kingdom) is the research group’s official commercial vehicle, advancing lead assets into late-stage preclinical development.
3,100,000 TRIO Pharmaceuticals, Inc. (CA, USA) is a cancer therapeutics company that develops dual-action drugs for immunogenic tumors.
3,806,865 Concinnity Genetics (United Kingdom) transform the safety of gene therapies by designing novel control mechanisms using AI platform.
5,287,810 Alveron Pharma (The Netherlands) produces drugs such as cyclodextrins, pro-coagualant cyclodextrins with a unique coagulation platform technology.
5,500,000 BioSapien (CA, USA) is a biotech startup that provides a drug delivery platform to deliver drugs for cancer treatment.
7,000,000 Portal (MA, USA) is a cell engineering platform firm that enables next generation cell engineering and cell analytics in research and clinical settings.
8,300,000 Promise Bio(Israel) is focused on pioneering precision medicine by utilizing epiproteomic analysis to understand autoimmune diseases.
9,566,159 Refoxy Pharma (Germany) is a developer of therapeutic medicines intended to treat age-related diseases and improve healthy longevity.
9,609,049 Signet Therapeutics Inc. (China) is a cutting-edge firm that conducts research and development on cancer-targeted drugs.
11,560,451 Orakl Oncology (France) is a precision oncology company that combines data and biology to bring new drugs to cancer patients.
15,000,000 Alessa Therapeutics, Inc. (CA, USA) develops localized treatments for solid organ disease.
34,000,000 GEMMA Biotherapeutics(PA, USA) is a new therapeutics company, will serve as the research and innovation arm to speed the research of and global access to life-changing advanced therapies for those living with rare diseases.
Unknown RenaissThera (India) is a biotechnology startup that uses AI platforms to produce low-cost, new small-molecule-targeted medicines.
Series A funding:
October:
2,342,074 Thioredoxin Systems AB (Sweden) develops innovative antibiotic regimen for complicated urinary tract infections.
8,805,955 AIGEN Sciences Inc. (South Korea) is an AI drug discovery platform that provides drug research and development services.
8,943,899 invIOs INNOVATIVE IMMUNO-ONCOLOGY s (Austria) is a private biotech company that specializes in the discovery and development of next-generation cancer therapies.
10,000,000 MiLaboratories (CA, USA) is a biotech company developing leading software platform for immune repertoire profiling
12,000,000 Aralez Bio (CA, USA) uses engineered enzymes to make valuable products in a sustainable way.
14,000,000 HealthEx (CA, USA) builds a patient-centric future for health data collaboration to unlock the next wave of precision medicine.
19,000,000 MARAbio (TN, USA) is a biotech firm that works to detect and prevent severe forms of Autism.
26,000,000 Alyssum Therapeutics (MA, USA) is a biotechnology company that focuses on developing next-generation immunotherapies to modulate B cells.
28,400,000 March Biosciences (TX, USA) is a clinical-stage cell therapy company that develops CAR-T cell strategies to address hematological cancers.
43,000,000 Arda Therapeutics (CA, USA) is taking aim at chronic diseases and aging by eliminating the pathogenic cells that drive these conditions.
43,000,000 LoQus23 Therapeutics Ltd (United Kingdom) is a DDF-formed company focussing on targeting DNA damage repair pathways to treat Huntington’s disease.
75,000,000 Judo Bio (MA, USA) is a biotechnology company that develops precision therapeutics targeting specific cell populations to address genetic diseases.
76,500,000 Blue Earth Therapeutics (United Kingdom) is a radiopharmaceutical company that specializes in the advancement of radiotherapeutics to treat cancer patients.
92,000,000 Kivu Bioscience (CA, USA) is a biotechnology company that focuses on developing next-generation antibody-drug conjugates to target cancer.
115,000,000 Axonis Therapeutics (MA, USA) is a neuro-focused biotechnology company that focuses on the development of novel neuromedicines.
135,000,000 City Therapeutics (MA, USA) is a biopharmaceutical company focused on developing next-generation small interfering RNAs.
400,000,000 Kailera Therapeutics(MA, USA) is developing a broad, advanced, and differentiated portfolio of clinical-stage injectable and oral therapies for the treatment of obesity and related conditions.
Unknown a:head bio AG (Austria) is a biotech company that provides a unique approach to drug development services.
November:
8,000,000 MetaSight Diagnostics (Israel) provides accurate, inexpensive, and accessible diagnostics for many diseases.
11,000,000 Doron Therapeutics (NC, USA) is a clinical-stage biotechnology company that has developed intra-articular biologic drug derived from placental tissue.
11,800,000 Freya Biosciences (MA, USA) is a clinical-stage women’s health company pioneering a new class of microbial immunotherapies.
Over 13,638,290 Leman Biotech (Switzerland) is a biotech company that is engaged in development of cancer immunotherapies.
13,819,026 Lingtai Biotechnology (China) is a pharmaceutical and biotechnology based company that develops targeted protein degradation drugs.
16,000,000 OneCell Diagnostics Inc. (India) is a Precision Oncology Liquid Biopsy Diagnostics Company.
16,750,000 Celosia Therapeutics (Australia) is a biotechnology company that uses gene therapy to treat neurodegenerative diseases.
21,059,725 Kanglin Biotech (China) is a national high-tech company that create first- and best-in-class revolutionary gene therapies.
42,000,000 Allink Biotherapeutics (China) is a biopharmaceutical company that focuses on oncology and immunological treatment.
57,059,894 atbtherapeutics (Belgium) is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.
101,000,000 Trace Neuroscience (CA, USA) is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients.
Unknown Avenzo Therapeutics (CA, USA) specializes in the development of oncology therapies for cancer treatment.
December:
8,382,496 Abselion (United Kingdom) is the biological sensor for rapid and cost-effective detection of biological substances like proteins, DNA, or small molecules.
10,000,000 Nintx (Next Innovative Therapeutics) (Brazil) involves advancing therapies to the end of preclinical studies, and Nintx develops therapies targeting biological pathways directly and indirectly through gut microbiome modulation.
10,000,000 Tracer Biotechnologies (NY, USA) are specialized in first-in-human studies with the use of nuclear and optical molecular imaging techniques.
10,000,000 DeepLife (France) is a biotech company with a mission to build the next generation of system biology. The company works in a highly collaborative translational manner, to facilitate the transition of discoveries from the laboratory to patients. Thecompany operates through collaboration with academic groups in their respective areas of expertise.
11,700,000 Hervolution Therapeutics (Denmark) develops immunotherapies targeting tumors using Human Endogenous Retroviral proteins (HERVs).
15,000,000 Syncell Inc(MA, USA) is a commercial stage life science company focused on subcellular protein purification and spatial proteomics analysis.
18,000,000 Biomemory(France) leverages molecular engineering to build exabyte appliances for data centers.
22,075,751 Cilcare (France) specializes in providing drug solutions for hearing and ear disorders.
25,000,000 Ambrosia Biosciences Inc. (CO, USA) offers drug development services for small molecule-based therapies for obesity and other metabolic disorders.
30,000,000 Borealis Biosciences, Inc. (Canada) is a company in the field of next-generation RNA medicines.
38,000,000 AQEMIA (France) is a pharmatech company developing a drug discovery platform to discover new drugs for specific therapeutic targets.
52,000,000 Tasca (MA, USA) is a biotechnology company that offers small molecule drugs for hard-to-treat oncology indications.
60,000,000 Akamis Bio(United Kingdom) is a clinical-stage oncology company whose mission is to leverage its groundbreaking T-SIGn® platform to positively impact the lives of people living with cancer.
84,098,100 Antag Therapeutics (Denmark) provides therapeutic peptides for the treatment of dietary-related metabolic diseases.
100,000,000 Syncromune® (FL, USA) is a clinical stage biopharmaceutical dedicated to the development of better immunotherapies for metastatic solid tumors.
140,000,000 Ottimo Pharma (UK/ MA, US) develops innovative cancer therapies using PD1-VEGFR2 antibodies.
Unknown Qihe Biotech (China) develops novel genome editing technologies with an emphasis on making them autonomous and programmable.
Series B funding:
October:
6,906,674 Alpha Fusion Inc. (Japan) is a clinical-stage startup committed to transforming cancer treatment through the design and development of powerful and precise radiopharmaceuticals.
16,000,000 OncoLens (GA, USA) has an AI-enabled digital healthcare platform, delivers data interoperability, actionable informatics, and next level collaboration to oncology care teams, researchers and administrators.
17,000,000 Rege Nephro Co., Ltd. (Japan) is a biotech company that specializes in R&D, production, and marketing of renal disease therapeutics.
32,500,000 Enara Bio(United Kingdom) is shining a light on Dark Antigen® and T-cell biology to develop cancer immunotherapies designed to improve treatment outcomes for broad populations of cancer patients.
34,000,000 Aignostics (Germany) is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research.
60,000,000 Basecamp Research(United Kingdom ) is a market leader in mapping biodiversity for AI-based design of biological systems.
85,000,000 Resolution Therapeutics (United Kingdom) is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.
92,000,000 SynOx Therapeutics Ltd (Ireland) is solely focused on developing emactuzumab, a best-in-class monoclonal antibody against CSF-1R, for the treatment of tenosynovial giant cell tumours (TGCT) and other macrophage-driven pathologies.
105,000,000 Purespring Therapeutics (United Kingdom) is a gene therapy company that provides treatments for different kidney diseases.
115,000,000 Triveni Bio (MA, USA) is a biotech company that develops functional antibodies targeting immunological and inflammatory disorders.
120,000,000 Terray Therapeutics (CA, USA) is a biotechnology company that transforms small molecule drug discovery.
225,000,000 Seaport Therapeutics(MA, USA)is a clinical-stage biopharmaceutical company advancing the development of novel neuropsychiatric medicines in areas of high unmet patient needs.
November:
20,000,000 Zucara Therapeutics Inc. (Canada) is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in patients with diabetes.
20,999,580 Nuwacell (Japan) focuses on the research and development, production and clinical transformation application of iPSC-derived cell therapy products.
73,000,000 Cradle (Switzerland) is a biotech company that uses prediction algorithms and AI design recommendations to assist biologists in designing proteins.
84,000,000 TRexBio (CA, USA) is a biotechnology company that treats diseases like cancer, fibrotic by studying human tissues.
135,000,000 Adcendo (Denmark) is a biotech company dedicated to developing new types of anti-cancer drugs.
215,000,000 Metsera (Denmark) develops oral and injectable therapies for obesity and metabolic diseases.
December:
16,000,000 Qnovia, Inc. (VA, USA) is a platform medtech and pharmaceutical company whose mission is to help save lives.
25,000,000 Pleno Inc.(CA, USA) is an early-stage startup company developing the RAPTORTM multi-omic instrument platform to revolutionize biological target detection and enable a broad array of life science applications.
40,579,533 KisoJi Biotechnology (Canada) is a biotechnology company focused on healthcare and life sciences for research and development industries.
73,000,000 AusperBio (China) is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other major infectious diseases.
89,720,936 Citryll (The Netherlands) is a developer of pharmaceutical drugs used to treat autoimmune and other human diseases.
147,000,000 Noema Pharma (Switzerland) is a biotech company that develops therapies to address disabling symptoms in conditions of the brain and nervous system.
161,000,000 Nuvig Therapeutics Inc. (CA, USA) is a biotechnology company developing therapies to induce natural mechanisms to restore immune homeostasis.
Series C funding:
October:
62,000,000 Pathos (IL, USA) is a clinical-stage biotechnology company focused on re-engineering drug development, leveraging the power of advanced AI technologies to bring precision medicines to market through partnerships with biopharmaceutical companies.
75,000,000 Nuclera (United Kingdom) offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers.
115,000,000 Evommune (CA, USA) is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.
175,000,000 Alpha-9 Oncology(Canada) is a clinical stage, radiopharmaceutical company developing differentiated and highly targeted radiopharmaceuticals with the potential to meaningfully improve the treatment of people living with cancer.
November:
130,000,000 Enveda (CO, USA) is a biotechnology company engineering new drugs from plants.
53,000,000 35Pharma (Canada) is a biopharmaceutical company that designs and develops innovative biologics for diseases of high unmet medical need.
16,500,000 Novelty Nobility Inc. (South Korea) is a private biotech company focused on the research of novel angiogenesis targets and develop antibody-based therapeutics.
14,900,000 MEPSGEN (South Korea) develops human microphysiological system for predictive model of human physiology, and unprecedented microfluidic modules from the lab-scale nanoparticle synthesis to automated large scale GMP manufacturing of lipid nanoparticles encapsulating mRNAs and ASOs.
December:
6,661,204 Craif Inc. (Japan) is a biotechnology company that develops a cancer diagnosis algorithm using microRNA database and machine learning technology.
100,000,000 SiteOne Therapeutics, Inc. (CA, USA) is a biopharmaceutical company that develops pain therapeutics to treat sensory hyperexcitability disorders.
120,000,000 Angitia Biopharmaceuticals (China) is a global biotechnology company focusing on the discovery and development of innovative therapeutics.
Series D funding:
October:
89,000,000 Agomab (Belgium) is a biotech company developing novel treatments that aim to preserve and restore organ function in fibrotic diseases. By translating a deep expertise in growth factor biology, we pioneer and develop novel treatments that aim to resolve fibrosis, repair tissue structure, and restore organ function.
100,000,000 Cytovale (CA, USA) is a medical diagnostics company focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases. Their FDA cleared IntelliSep test is pioneering a new way of quickly and accurately analyzing white blood cells to stratify a patient’s risk of sepsis by performing a biomechanical evaluation of white blood cells collected from a standard blood draw in under 10 minutes.
Unknown Vizgen (MA, USA) is a biotech company that develops solutions for next-generation spatially resolved, single-cell transcriptomics. Along with their Series D funding they also announced a merger with Ultivue, Inc., a market leader in multiplex proteomic biomarker detection and advanced AI-driven spatial tissue profiling
November:
34,000,000 PrognomiQ Inc (CA, USA) is a biotechnology firm that develops test products to detect early disease detection through the power of multi-omics data.
34,566,194 IMPACT Therapeutics, Inc. (China) is a therapeutics company dedicated to the development of similar drugs to treat cancer.
181,400,000 Alentis Therapeutics (Switzerland) is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer.
December:
31,536,788 miDiagnostics (Belgium) is developing a next-generation diagnostic platform based on a silicon nanofluidic processor.
115,000,000 Maze Therapeutics (CA, USA) is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.
Series E funding:
October:
42,147,855 TenNor Therapeutics (NJ, USA) specializes in research and development of new drugs for the treatment of digestive diseases.
If you’re a life science startup looking for talent, or you’d like to learn more about our recruitment services, submit your vacancy and a recruitment consultant that specialises in your biotech field will be in touch shortly.
Alternatively, are you seeking advice on your next move? I’m here to help. Register with us today to schedule a confidential discussion about your career prospects.
